SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001213900-23-089654
Filing Date
2023-11-22
Accepted
2023-11-22 17:14:35
Documents
13
Period of Report
2023-11-21
Items
Item 5.03: Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year
Item 5.07: Submission of Matters to a Vote of Security Holders
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 CURRENT REPORT ea188953-8k_tffpharm.htm   iXBRL 8-K 54211
2 CERTIFICATE OF AMENDMENT TO SECOND AMENDED AND RESTATED CERTIFICATE OF INCORPORA ea188953ex3-1_tffpharm.htm EX-3.1 10394
  Complete submission text file 0001213900-23-089654.txt   244539

Data Files

Seq Description Document Type Size
3 XBRL SCHEMA FILE tffp-20231121.xsd EX-101.SCH 3018
4 XBRL LABEL FILE tffp-20231121_lab.xml EX-101.LAB 34240
5 XBRL PRESENTATION FILE tffp-20231121_pre.xml EX-101.PRE 22361
7 EXTRACTED XBRL INSTANCE DOCUMENT ea188953-8k_tffpharm_htm.xml XML 3503
Mailing Address 2600 VIA FORTUNA, SUITE 360 AUSTIN TX 78746
Business Address 2600 VIA FORTUNA, SUITE 360 AUSTIN TX 78746 737-802-1973
TFF Pharmaceuticals, Inc. (Filer) CIK: 0001733413 (see all company filings)

IRS No.: 824344737 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-39102 | Film No.: 231434421
SIC: 2834 Pharmaceutical Preparations